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protocol was initiated in 36 patients with a average baseline blood glucose 2.7 
± 0,7g/l. thirty-two were diabetics (31 type 2 and 1 and type 1) and diabete mel-
litus has been found on the occasion of the SCA in 4 of them with HbA1c 
>6.5%. The average time to reach a glycemia within the target range was 12.7 
± 11h. Only 3 patients (8%) had moderate hypoglycemia (<0.70g / l) and there 
were no severe hypoglycemia.
Conclusion: In this study, 59% of patients are diabetics, know or revealed 
at the opportunity of SCA, higher than the usual literature data. Hypergly-
cemia at admission reveals glucose disorder in 53% of cases. Our IV insulin 
protocol is safe and efficient.
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Introduction and Objectives: Little attention has been given to the effect 
of vascular access site on mortality, while an increasing body of evidence is 
showing that radial access has much more benefit than femoral access for ST-
segment elevation myocardial infarction patients. We aimed to assess the 
influence of vascular access site on mortality at 30 days and at 1 year in ST-
segment elevation myocardial infarction patients.
Methods: We included all patients with ST-segment elevation myocardial 
infarction who had undergone angioplasty at military hospitals of Constantine 
and Algiers and the hospital of erriadh (ESH erriadh) between 2010 and 2013. 
We performed 2 multivariate regression models for each endpoint (30-day and 
1-year mortality). The only difference between these models was the inclusion 
or not of the vascular access site (femoral vs radial). We also tested the inter-
action between hemodynamic instability and vascular access.
Results: We included 395 patients with a mean age of 62. Of these 
patients, 32% had radial access and 7.4% had hemodynamic instability. All-
cause mortality was 8.6% (34/395) at 30 days and 13.1% (52/395) at 1 year. 
Vascular access site follows hemodynamic instability and age in terms of 
effect on mortality risk, with an odds ratio of 5.20 (95% confidence interval, 
2.80-9.66) for 30-day mortality. A similar effect occurs for 1-year mortality.
Conclusions: Vascular access site should be taken into account when pre-
dicting mortality after a primary percutaneous coronary intervention.
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Introduction and Objectives: Little is known about how prognosis is 
influenced by readmission for acute heart failure (AHF) following non-ST-
segment elevation acute coronary syndrome (NSTEACS). The aim of this 
study was to determine the prognostic effect of a first admission for AHF on 
the risk of acute myocardial infarction (AMI) or death in patients who sur-
vived an episode of high-risk NSTEACS.
Methods: The study involved 342 consecutive patients with high-risk 
NSTEACS who survived after hospital admission in military hospital of 
Algiers and Constantine. Readmission for AHF was selected as the main 
exposure variable, and its association with subsequent AMI or all-cause death 
was assessed using Cox proportional hazards models for time-dependent 
covariates that also included adjustment for competing risks. Results: After a 
median follow-up period of 30 [interquartile range, 12-48] months, 29 patients 
(8.4%) were admitted for AHF, 51(15%) had an AMI, and 71 (20.8%) died. 
The median time to readmission for AHF was 193 [56-336] days after 
NSTEACS. Patients readmitted for AHF had an increased risk of subsequent 
death (hazard ratio [HR]=1.67; 95% confidence interval [CI], 1.13-2.45; 
P=.009) or AMI (HR=2.15; 95% CI, 1.41-3.27; P<.001), which was indepen-
dent of baseline prognostic and time-dependent variables.
Conclusions: Readmission for AHF after high-risk NSTEACS was associ-
ated with an increased risk of subsequent death or AMI.
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Introduction: Decreased glomerular filtration rate (GFR) is associated 
with an increased risk of cardiovascular events following acute ST elevation 
myocardial infarction (STEMI). However, patients with chronic kidney dis-
ease have more comorbidities and will receive fewer evidence-based therapies
In a prospective STEMI patient cohort we assessed the effect of an optimal 
therapeutic management (OTM) according to GFR categories on long-term 
all-cause mortality.
Methods: In a single tertiary referral center, 1,199 patients admitted for 
acute STEMI were enrolled between 2007 and 2011. We classified patients 
into 4 categories according to estimated GFR, <45, 45 to 60, 60 to 90, and 
>90mL/min/1,73m2 with the Chronic Kidney Disease Epidemiology Collabo-
ration (CKD EPI) equation. Optimal therapeutic management was defined as 
a combination of reperfusion within 12 hours of symptom onset, primary 
percutaneous coronary intervention (PCI), double anti-platelet regimen, 
angiotensin converting enzyme inhibitors, statins, beta blockers, and anti-
aldosterone treatment (if left ventricle ejection fraction <40%) upon discharge. 
The effect of OTM on survival according to GFR categories was analysed in 
a multivariate survival model including other risk factors and using a propen-
sity score method. Long-term mortality was the principal endpoint.
Results: Patients were followed-up for a median of 4.7 years and 
148(12.3%) patients died. OTM was applied in 431 (39.1%) patients of our 
cohort and overall, was associated with a significantly lower mortality (HR of 
0.43 [95% CI, 0.26-0.70; P<0.001). There was a significant mortality reduc-
tion in the OTM group compared to the non-OTM group that tended to 
increase with increasing levels of renal dysfunction (HR of 0.28 [95% CI, 
0.13-0.61] in the eGFR<60ml/min patient subgroup; P=0.001) (Figure 1). 
Conclusions: OTM lowers long-term mortality whatever the eGFR cate-
gory and with a trend towards increased efficiency with increasing levels of 
renal dysfunction.
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